Frontiers in Immunology

Editorial

Published on 15 May 2023

Editorial: Controversies and expectations for prevention and treatment of graft-versus-host-disease: a biological and clinical perspective

in Alloimmunity and Transplantation

Jacopo Mariotti
Daniel H. Fowler
Stefania Bramanti
Steve Z. Pavletic

Frontiers in Immunology

doi 10.3389/fimmu.2023.1212756

1,582 views
1 citation

Original Research

Published on 15 May 2023

Data driven model discovery and interpretation for CAR T-cell killing using sparse identification and latent variables

in Cancer Immunity and Immunotherapy

Alexander B. Brummer
Agata Xella
Ryan Woodall
Vikram Adhikarla
Heyrim Cho
Margarita Gutova
Christine E. Brown
Russell C. Rockne

Frontiers in Immunology

doi 10.3389/fimmu.2023.1115536

6,875 views
29 citations

Review

Published on 15 May 2023

New molecular targets in Hodgkin and Reed-Sternberg cells

in Cancer Immunity and Immunotherapy

Hummaira Sadaf
Maciej Ambroziak
Robert Binkowski
Jakkapong Kluebsoongnoen
Ewa Paszkiewicz-Kozik
Jaroslaw Steciuk
Sergiusz Markowicz
Jan Walewski
Elzbieta Sarnowska
Tomasz Jacek Sarnowski

Frontiers in Immunology

doi 10.3389/fimmu.2023.1155468

6,257 views
7 citations

Review

Published on 15 May 2023

Monoclonal antibodies for prophylaxis and therapy of respiratory syncytial virus, SARS-CoV-2, human immunodeficiency virus, rabies and bacterial infections: an update from the World Association of Infectious Diseases and Immunological Disorders and the Italian Society of Antinfective Therapy

in Vaccines and Molecular Therapeutics

Susanna Esposito
Gayatri Amirthalingam
Matteo Bassetti
Francesco Blasi
Francesco Giuseppe De Rosa
Natasha B. Halasa
Ivan Hung
Albert Osterhaus
Tina Tan
Juan Pablo Torres

Frontiers in Immunology

doi 10.3389/fimmu.2023.1162342

14,482 views
24 citations

Original Research

Published on 15 May 2023

Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq

in Cancer Immunity and Immunotherapy

Pengpeng Zhang
Jianlan Liu
Shengbin Pei
Dan Wu
Jiaheng Xie
Jinhui Liu
Jun Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1189520

12,847 views
31 citations

Original Research

Published on 15 May 2023

ATM and ATR, two central players of the DNA damage response, are involved in the induction of systemic acquired resistance by extracellular DNA, but not the plant wound response

in Molecular Innate Immunity

Isaac Vega-Muñoz
Alfredo Herrera-Estrella
Octavio Martínez-de la Vega
Martin Heil

Frontiers in Immunology

doi 10.3389/fimmu.2023.1175786

6,017 views
12 citations

Case Report

Published on 15 May 2023

Conversion of primary liver cancer after targeted therapy for liver cancer combined with AFP-targeted CAR T-cell therapy: a case report

in Cancer Immunity and Immunotherapy

Yun Wang
Yan Zhao
Miaoling Li
Huilian Hou
Zhijie Jian
Weizhi Li
Peijie Li
Fuquan Ma
Mengying Liu
Haibo Liu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1180001

5,711 views
18 citations

Case Report

Published on 15 May 2023

Case Report: Optic neuritis as the initial presentation of Orientia tsutsugamushi infection detected by metagenomic next-generation sequencing

in Microbial Immunology

Chuan-bin Sun
Zhiqiong Ma
Zhe Liu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1129246

3,315 views
9 citations

Original Research

Published on 15 May 2023

Cx3cr1 controls kidney resident macrophage heterogeneity

in Molecular Innate Immunity

Alex Yashchenko
Sarah J. Bland
Cheng J. Song
Ummey Khalecha Bintha Ahmed
Rachel Sharp
Isabella G. Darby
Audrey M. Cordova
Morgan E. Smith
Jeremie M. Lever
Zhang Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1082078

12,200 views
10 citations

Review

Published on 15 May 2023

Targeting protein glycosylation to regulate inflammation in the respiratory tract: novel diagnostic and therapeutic candidates for chronic respiratory diseases

in Inflammation

Xiaofeng Xie
Siyuan Kong
Weiqian Cao

Frontiers in Immunology

doi 10.3389/fimmu.2023.1168023

7,466 views
17 citations

Original Research

Published on 15 May 2023

Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression

in Cancer Immunity and Immunotherapy

Afsheen Raza
Reyad Mohsen
Aladdin Kanbour
Abdul Rehman Zar Gul
Anite Philip
Suma Vijayakumar
Shereena Hydrose
Kirti S. Prabhu
Aisha Khamis Al-Suwaidi
Varghese Philipose Inchakalody

Frontiers in Immunology

doi 10.3389/fimmu.2023.1157100

5,207 views
12 citations

Review

Published on 15 May 2023

From bench to bedside: the history and progress of CAR T cell therapy

in Cancer Immunity and Immunotherapy

Aroshi Mitra
Amrita Barua
Luping Huang
Siddhartha Ganguly
Qin Feng
Bin He

Frontiers in Immunology

doi 10.3389/fimmu.2023.1188049

151,214 views
292 citations

Mini Review

Published on 15 May 2023

The importance of biomarker development for monitoring type 1 diabetes progression rate and therapeutic responsiveness

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Maxwell J. Fyvie
Kathleen M. Gillespie

Frontiers in Immunology

doi 10.3389/fimmu.2023.1158278

9,214 views
18 citations

Mini Review

Published on 15 May 2023

Single-cell sequencing technology in colorectal cancer: a new technology to disclose the tumor heterogeneity and target precise treatment

in Cancer Immunity and Immunotherapy

Rongbo Wen
Leqi Zhou
Zhiying Peng
Hao Fan
Tianshuai Zhang
Hang Jia
Xianhua Gao
Liqiang Hao
Zheng Lou
Fuao Cao

Frontiers in Immunology

doi 10.3389/fimmu.2023.1175343

11,838 views
20 citations

Systematic Review

Published on 15 May 2023

Indeterminate results of interferon gamma release assays in the screening of latent tuberculosis infection: a systematic review and meta-analysis

in Microbial Immunology

Guozhong Zhou
Qingyi Luo
Shiqi Luo
Hongbo Chen
Shunli Cai
Xin Guo
Jian He
Yuan Xia
Hanse Li
Yingchen Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2023.1170579

10,291 views
32 citations

Original Research

Published on 15 May 2023

Human cytomegalovirus and Epstein–Barr virus infections occurring early after transplantation are risk factors for antibody-mediated rejection in heart transplant recipients

in Alloimmunity and Transplantation

Alda Saldan
Carlo Mengoli
Dino Sgarabotto
Marny Fedrigo
Annalisa Angelini
Giuseppe Feltrin
Antonio Gambino
Gino Gerosa
Luisa Barzon
Davide Abate

Frontiers in Immunology

doi 10.3389/fimmu.2023.1171197

4,176 views
9 citations